Harvey Capital Management’s Clorox CLX Stock Holding History

Harvey Capital Management’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-14,300	Closed	-$2.48M	–	75
2020 Q1	$2.48M	Buy	+14,300	New	+$2.36M	1.67%	18

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Harvey Capital Management's CLX Position: Q2 2020 in Review

Harvey Capital Management sold out of Clorox (CLX) in Q2 2020, closing a stake of 14,300 shares — an estimated $2.48M sold.

Harvey Capital Management first reported a position in CLX in Q1 2020 and held it in 1 quarter. The position peaked at $2.48M in Q1 2020. 1,197 funds tracked by Wall St. Rank hold CLX as of Q2 2020.

Harvey Capital Management reported no remaining Clorox position as of Q2 2020 after selling out during the quarter.
Harvey Capital Management sold 14,300 Clorox shares in Q2 2020, an estimated $2.48M.
Harvey Capital Management first reported a position in Clorox in Q1 2020 and held it in 1 quarter.
Harvey Capital Management's Clorox position peaked at $2.48M in Q1 2020.
1,197 funds tracked by Wall St. Rank held Clorox as of Q2 2020.

Based on Harvey Capital Management's 13F filing for Q2 2020, filed 5 Aug 2020.